AI Verdict
MIRM has stronger fundamentals based on our AI analysis.
MIST vs MIRM Fundamental Comparison
| Metric | MIST | MIRM |
|---|---|---|
| Revenue | N/A | $521.3M |
| Net Income | $-63.1M | $-23.4M |
| Net Margin | N/A | -4.5% |
| ROE | -151.0% | -7.4% |
| ROA | -55.5% | -2.8% |
| Current Ratio | 8.01x | 2.67x |
| Debt/Equity | 1.37x | 0.00x |
| EPS | $-0.75 | $-0.47 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
MIST vs MIRM: Frequently Asked Questions
Is MIST or MIRM a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), MIRM has stronger fundamentals. MIST is rated STRONG SELL (92% confidence) while MIRM is rated HOLD (62% confidence). This is not investment advice.
How does MIST compare to MIRM fundamentally?
Milestone Pharmaceuticals Inc. has ROE of -151.0% vs Mirum Pharmaceuticals, Inc.'s -7.4%. Net margins are N/A vs -4.5% respectively.
Which stock pays higher dividends, MIST or MIRM?
MIST has a dividend yield of N/A or no dividend while MIRM has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in MIST or MIRM for long term?
For long-term investing, consider that MIST has STRONG SELL rating with 92% confidence, while MIRM has HOLD rating with 62% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about MIST vs MIRM?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For MIST vs MIRM, the AI consensus favors MIRM based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.